Acute reduction of anandamide-hydrolase (FAAH) activity is coupled with a reduction of nociceptive pathways facilitation in medication-overuse headache subjects after withdrawal treatment.
OBJECTIVE
We investigated (1) a possible relationship between the functional activity of the endocannabinoid system and the facilitation of pain processing in migraineurs with medication-overuse headache, and (2) the effect of withdrawal treatment on both.


BACKGROUND
The endocannabinoid system antinociception effect includes prevention of nociceptive pathways sensitization. The sensitization of the pain pathways has been demonstrated to be pivotal in the development and maintenance of chronic form of migraine, including medication-overuse headache.


METHODS
We used the temporal summation threshold of the nociceptive withdrawal reflex to explore the spinal cord pain processing, and the platelet activity of the enzyme fatty acid amide hydrolase to detect the functional state of the endocannabinoid system in 27 medication-overuse headache subjects before and 10 and 60 days after a standard withdrawal treatment and compared results with those of 14 controls.


RESULTS
A significantly reduced temporal summation threshold and increased related pain sensation was found in subjects before withdrawal treatment when compared with controls. A significant fatty acid amide hydrolase activity reduction coupled with a significant improvement (reduction) in facilitation of spinal cord pain processing (increase in temporal summation threshold and reduction in related pain sensation) was found in medication-overuse headache subjects at both 10 and 60 days after withdrawal treatment when compared with medication-overuse headache subjects before withdrawal treatment.


CONCLUSIONS
We demonstrated a marked facilitation in spinal cord pain processing in medication-overuse headache before withdrawal treatment when compared with controls. Furthermore, the acute reduction of the fatty acid amide hydrolase activity coupled with a reduction of the facilitation in pain processing immediately (10 days) after withdrawal treatment and its persistence 60 days after withdrawal treatment could represent the consequence of a mechanism devoted to acutely reduce the degradation of endocannabinoids and aimed to increase the activity of the endocannabinoid system that results in an antinociceptive effect.
Headache Clinic, IRCCS Mediterranean Neurological Institute Neuromed, Pozzilli, Italy. arm.perrotta@gmail.com
Armando
A
Perrotta
Natalia
N
Arce-Leal
Cristina
C
Tassorelli
Valeria
V
Gasperi
Grazia
G
Sances
Fabio
F
Blandini
Mariano
M
Serrao
Monica
M
Bolla
Francesco
F
Pierelli
Giuseppe
G
Nappi
Mauro
M
Maccarrone
Giorgio
G
Sandrini
D000328:Adult; D000581:Amidohydrolases / Q000378:metabolism*; D000700:Analgesics / Q000009:adverse effects; D005260:Female; D006261:Headache / Q000139:chemically induced / Q000378:metabolism* / Q000503:physiopathology; D006801:Humans; D008297:Male; D009434:Neural Pathways / Q000378:metabolism / Q000503:physiopathology; D010146:Pain / Q000378:metabolism* / Q000503:physiopathology; D017288:Pain Threshold / Q000502:physiology; D012018:Reflex / Q000502:physiology; D019966:Substance-Related Disorders / Q000150:complications; D000099252:Fatty Acid Amide Hydrolases
D000581:Amidohydrolases; D000700:Analgesics; D000099252:Fatty Acid Amide Hydrolases